In alliance with Polarean, Philips is rolling out a new MR system with advanced multi-nuclei imaging capabilities that will offer radiologists a detailed evaluation of lung ventilation using xenon gas as a contrast agent.

The ACR Manual on Contrast Media suggests that highly viscous ICM should be warmed to body temperature prior to administration when using high-rate intravenous low-osmolality power injections, viscous iodinated CM, small-caliber catheters, or for timed studies looking at peak enhancement.   

The ACR Committee on Drugs and Contrast Media stated that exposure to the gadolinium-based contrast agent represents a “sufficiently low or possibly nonexistent” risk to patients.

The new data highlight a potential pitfall of unenhanced CT scans on patients presenting to emergency departments with acute pain—an inaccurate workup.

The update marks a change from the FDA's stance on the topic last year.

New research compares peak enhancement timing of a patient-specific post-trigger delay and a fixed delay during CCTA.

Up to one-third or more of patients who experience moderate or severe allergic-like reactions to ICM must have their imaging protocols revised when subsequent exams involving contrast are requested.

The use of synthetic images could reduce the amount of gadolinium-based contrast agents needed for breast MRI examinations, according to new data published this week in Radiology.